maxluke, I hadn't seen TSBX or IKNA...keep the newby nosedive cashfat-biobusts coming, thanks.. With all the recent biotech IPO's of the past few years, surely more will nosedive into lucrative oppurtunities.
I also continue to hold a sizeable position in OMIC and into a probable Reverse-Split which will certainly be advantageous to OMIC imo, altho I fully expect the madding crowd might take it the wrong way - lol.
XLO, AMLX, and VNDA are my fav's du jour...
especially VNDA @ 5.60 - approx. $7.00 BV, a $7 - $12 buyout offer on the table, a PDUFA date for "tradipant" on 9/18/24, Real Revenue/Minimal Burn, and very lucrative option premiums...and an announced Q1 filing after tomorrow's close which I fully expect them to re-hype all of the above.
